精华制药：公司布局有玛巴洛沙韦等产品
JINGHUA PHARMACEUTICAL GROUP CO.(SZ:002349) Di Yi Cai Jing·2025-11-26 12:11Group 1 - The company is currently focusing on the development of products such as Mabalosavir, with ongoing optimization work for its manufacturing process [1]